Tag Archives: Irinotecan

New Hope for Patients with Advanced Metastatic Colorectal Cancer Patients

Posted on March 11, 2012 by wngai

Colorectal cancer is the fourth most common cancer in men and women with nearly 500,000 deaths due to colorectal cancer every year. When detected early at localized stage I, the 5-year survival rate can reach 90%. At this stage, surgical … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged 5-Fluorouracil, Avastin, bevacizumab, camptosar, Cetuximab, Eloxatin, Erbitux, gastrointestinal stromal tumors, GIST, Gleevec, imatanib, Irinotecan, leucovorin, metastatic colorectal cancer, oxaliplatin, regoragenib, sunitinib, Survival, Sutent | Comments Off

Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?

Posted on December 22, 2010 by wngai

A large study of patients with newly diagnosed glioblastoma multiforme suggests that the addition of bevacizumab (Avastin) and irinotecan (Camptosar) to standard chemoradiation can extend survival (progression and overall survival) by 6 months. Bevacizumab (Avastin) is an inhibitor of vascular … Continue reading →

Posted in Cancer, Glioblastma | Tagged Avastin, bevacizumab, camptosar, chemoradiation, glioblastoma multiforme, Irinotecan, progression-free survival, Survival, Temodar, temozolomide | Comments Off

Ancient Chinese Herbal Medicine Reduces Side-Effects of Chemotherapy

Posted on August 22, 2010 by wngai

A Chinese herbal formula that was used more than 1,800 years ago was shown to reduce the gastrointestinal side effects of chemotherapy but also increased its efficacy in mice, according to a study published in the August issue of the … Continue reading →

Posted in Cancer, Colorectal cancer, Herbal Medicine | Tagged camptosar, chemotherapy, Chinese herbal medicine, colorectal cancer, efficacy, Herbal Medicine, Herbal Medicine, Huang Qin Tang, Irinotecan, jujube, licorice, peony, side-effects, skullcap | 3 Comments

Alternative 1st Treatment for Small-Cell Lung Cancer Patients with Extensive Disease

Posted on March 28, 2010 by wngai

Lung cancer is the most common diagnosed cancer worldwide and small-cell lung cancer (SCLC) accounts for only 10%-15% of lung cancer cases. Etoposide in combination with cisplatin (EP) or carboplatin is currently considered the standard of care in most countries, but … Continue reading →

Posted in Cancer, Lung Cancer | Tagged 1st line, Cisplatin, Etoposide, Irinotecan, Small Cell Lung Cancer, Survival, Treatment | Comments Off